Released: ·Last reviewed: ·Methodology v4.1
GLP-1 side effects: what to expect and when to worry
The most common GLP-1 side effects are gastrointestinal — nausea, diarrhea, vomiting and constipation — and are usually strongest during dose escalation. Serious but less common risks include pancreatitis and gallbladder disease. A boxed warning covers thyroid C-cell tumors based on rodent data.
Common side effects
Nausea, diarrhea, vomiting, constipation and abdominal discomfort dominate, especially during titration. Slower dose escalation, smaller meals and hydration help many patients. These usually ease as the body adjusts.
Serious risks
Pancreatitis, gallbladder disease and, in rodent studies, thyroid C-cell tumors are the notable serious risks. The thyroid signal drives a boxed warning and a contraindication for personal or family history of medullary thyroid carcinoma or MEN 2.
Managing side effects
Clinician-directed titration is the single most effective lever. Antiemetics, dietary adjustment and dose holds are common tools. Persistent or severe symptoms warrant clinical review, not self-management.
Frequently asked questions
How long do GLP-1 side effects last?
Most gastrointestinal effects are worst during dose increases and ease within days to weeks as the body adjusts. Persistent symptoms should be reviewed by a clinician.
When should I seek urgent care?
Severe or persistent abdominal pain (possible pancreatitis), signs of an allergic reaction, or gallbladder symptoms warrant urgent care, not telehealth follow-up.
Sources
- U.S. Food and Drug Administration — labels and safety communications.
- Peer-reviewed clinical trials cited above.
- Our methodology and medical review policy.